200 related articles for article (PubMed ID: 15902277)
1. Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer.
Worthington J; Robson T; Scott S; Hirst D
Gene Ther; 2005 Oct; 12(19):1417-23. PubMed ID: 15902277
[TBL] [Abstract][Full Text] [Related]
2. The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
Coulter JA; McCarthy HO; Worthington J; Robson T; Scott S; Hirst DG
Gene Ther; 2008 Apr; 15(7):495-503. PubMed ID: 18256696
[TBL] [Abstract][Full Text] [Related]
3. p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.
McCarthy HO; Worthington J; Barrett E; Cosimo E; Boyd M; Mairs RJ; Ward C; McKeown SR; Hirst DG; Robson T
Gene Ther; 2007 Feb; 14(3):246-55. PubMed ID: 17006546
[TBL] [Abstract][Full Text] [Related]
4. Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy.
Worthington J; Robson T; O'Keeffe M; Hirst DG
Gene Ther; 2002 Feb; 9(4):263-9. PubMed ID: 11896465
[TBL] [Abstract][Full Text] [Related]
5. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
McCarthy HO; Coulter JA; Worthington J; Robson T; Hirst DG
J Gene Med; 2007 Jun; 9(6):511-20. PubMed ID: 17471586
[TBL] [Abstract][Full Text] [Related]
6. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
Scott SD; Joiner MC; Marples B
Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
[TBL] [Abstract][Full Text] [Related]
7. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.
Adams C; McCarthy HO; Coulter JA; Worthington J; Murphy C; Robson T; Hirst DG
J Gene Med; 2009 Feb; 11(2):160-8. PubMed ID: 19062185
[TBL] [Abstract][Full Text] [Related]
10. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
Wang CY; Wang S
Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
[TBL] [Abstract][Full Text] [Related]
11. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds.
Thornton FJ; Schäffer MR; Witte MB; Moldawer LL; MacKay SL; Abouhamze A; Tannahill CL; Barbul A
Biochem Biophys Res Commun; 1998 May; 246(3):654-9. PubMed ID: 9618268
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.7 macrophage cells.
Jung KH; Ha E; Kim MJ; Won HJ; Zheng LT; Kim HK; Hong SJ; Chung JH; Yim SV
Food Chem Toxicol; 2007 Aug; 45(8):1545-50. PubMed ID: 17418925
[TBL] [Abstract][Full Text] [Related]
13. Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model.
Cao YJ; Shibata T; Rainov NG
Gene Ther; 2002 Mar; 9(6):415-9. PubMed ID: 11960318
[TBL] [Abstract][Full Text] [Related]
14. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro.
Coughlan T; Gibson C; Murphy S
J Neurochem; 2005 May; 93(4):932-42. PubMed ID: 15857396
[TBL] [Abstract][Full Text] [Related]
16. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.
Vila-del Sol V; Díaz-Muñoz MD; Fresno M
J Leukoc Biol; 2007 Jan; 81(1):272-83. PubMed ID: 17035338
[TBL] [Abstract][Full Text] [Related]
17. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation.
Granja AG; Sabina P; Salas ML; Fresno M; Revilla Y
J Virol; 2006 Nov; 80(21):10487-96. PubMed ID: 17041221
[TBL] [Abstract][Full Text] [Related]
19. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
Huang D; Desbois A; Hou ST
Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline-inducible transgene expression mediated by a single AAV vector.
Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
